Treatment of Noncirrhotic Non-Alcoholic Steatohepatitis
Manufacturer By
Zydus Bionext
Availability
In Stock
Key Features
Manages High Triglycerides – Bilypsa contains Saroglitazar, an innovative dual PPAR α/γ agonist that helps reduce elevated triglyceride and cholesterol levels.
Useful in Diabetic Dyslipidemia & NAFLD/NASH – Indicated for managing diabetic dyslipidemia, hypertriglyceridemia, and improving liver health in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
Improves Insulin Sensitivity – Enhances glycemic control and insulin sensitivity, making it beneficial for patients with type 2 diabetes and related metabolic conditions.
Liver & Heart Protection – Supports cardiovascular health by lowering lipid levels and helps reduce fat accumulation in the liver.
Find products similar to Bilypsa Saroglitazar Tablets
Interested in this product?Get Latest Price from the seller
About the Company
GST Registration Date
16-05-2023
Legal Status of Firm
Partnership
Nature of Business
Trader - Wholesaler/Distributor
Number of Employees
Upto 10 People
Annual Turnover
5 - 25 Cr
IndiaMART Member Since
May 2025
GST
27AATFJ2053P1ZO
Jai Mata Dee Pharma is a reliable wholesaler of medicines, dedicated to serving pharmacies, hospitals, and healthcare providers with quality pharmaceutical products. We ensure authenticity, affordability, and prompt supply through our strong distribution network. With a customer-first approach and ethical business practices, we aim to be a trusted partner in supporting better healthcare delivery.
